MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
100.95
-0.12
-0.12%
After Hours: 100.50 -0.45 -0.45% 19:34 08/07 EDT
OPEN
101.05
PREV CLOSE
101.07
HIGH
101.28
LOW
100.73
VOLUME
2.08M
TURNOVER
--
52 WEEK HIGH
111.86
52 WEEK LOW
47.25
MARKET CAP
6.59B
P/E (TTM)
24.42
1D
5D
1M
3M
1Y
5Y
1D
Best Buy, Yarrow, Apple, Lantheus, Intuit Trending With Analysts
TipRanks · 1d ago
Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH
Barchart · 2d ago
Analysts Conflicted on These Healthcare Names: Lexicon Pharmaceuticals (LXRX), Ascendis Pharma (ASND) and Lantheus (LNTH)
TipRanks · 3d ago
*Lantheus Holdings 2Q EPS $1.11 >LNTH
Dow Jones · 3d ago
*Lantheus Holdings 2Q Net $75M >LNTH
Dow Jones · 3d ago
*Lantheus Holdings 2Q Rev $388.2M >LNTH
Dow Jones · 3d ago
*Lantheus Holdings 2Q Adj EPS $1.55 >LNTH
Dow Jones · 3d ago
Lantheus Holdings: Q2 Earnings Snapshot
Barchart · 3d ago
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. Its product categories include oncology, neurology, cardiology, and strategic partnerships and others. Its products include PYLARIFY, Neuraceq, and DEFINITY. PYLARIFY TruVu is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy, or suspected recurrence based on elevated serum prostate-specific antigen (PSA). Neuraceq is an Alzheimer's disease radiodiagnostic. Its commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists across a range of clinical care settings. Its diagnostic products provide information that enables healthcare professionals (HCPs) to better detect, characterize, or rule out diseases.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.